Your Cart is Empty
PDRN and polynucleotides, often shortened to PN, are related terms that are used inconsistently in skincare and aesthetic medicine. In dermatology, PDRN usually refers to processed DNA-fragment mixtures, while PN often describes longer DNA-derived polymers. There is no universally standardized molecular-weight boundary that lets a label alone establish equivalence.
A polynucleotide is a chain of nucleotide units. In broad biology the term can include RNA or DNA; in the dermatology literature discussed here, PN/PDRN generally refers to DNA-derived preparations. PDRN spells out polydeoxyribonucleotide. These are nucleic-acid materials, not amino-acid peptides or structural ceramide lipids.
| Feature | PDRN descriptions | PN descriptions |
|---|---|---|
| Fragment profile | Usually lower- to medium-length processed DNA mixtures | Often longer DNA-derived chains. |
| Research emphasis | Pharmacological signaling and nucleotide-salvage observations | Material viscosity, hydration and structural behavior, alongside biological hypotheses. |
| What must be specified | Source, process, distribution, purity and formulation | The same information, including the actual polymer preparation. |
| Main limitation | A name is not a universal composition standard | A name is not proof of a distinct, standardized treatment. |
These are tendencies in published descriptions, not guarantees about every supplier. A 2025 review proposed a molecular-weight cutoff to improve terminology. Another 2025 comparison noted that established standardized thresholds remain lacking. A proposal should not be repeated as a universal regulatory or chemical definition.
Fragment length, charge, concentration and the surrounding vehicle influence material behavior. A more viscous injectable PN preparation and a watery cosmetic serum can have different intended functions even when both use DNA-derived ingredients. The presence of DNA fragments does not make a cosmetic sterile or suitable for injection.
PDRN research includes adenosine-related activity and reuse of nucleotide building blocks. Descriptions of longer PN materials may emphasize water interaction and matrix-like behavior. Neither mechanism is a shortcut to a cosmetic claim: the actual preparation still needs evidence for its route and endpoint. Topical versus injectable evidence addresses that next step.
A name such as Sodium DNA or Hydrolyzed DNA can help identify a DNA-related ingredient. It does not necessarily disclose fragment distribution, source, purity or correspondence with a trial preparation. Ask for material characterization instead of assuming that a familiar INCI name means a particular medical product was included. “PN serum” and “PDRN serum” also need a clear topical intended use.
Choose by transparent formula information, realistic cosmetic goals and tolerance. No acronym wins for every skin type. If a source or vegan claim is central to your choice, verify it separately. For a buying decision, the PDRN serum selection guide is more useful than treating related names as proof of identical performance.
Reviewed October 5, 2026. Educational skincare guidance; medical and procedural care requires an appropriate clinician.
